Weijing Medical Funding: $71M Raised, Series B (2025)
Weijing Medical is based in Hangzhou, China. It has raised $71M in total funding. Latest round: Series B.
Weijing Medical funding overview
Weijing Medical is based in Hangzhou, China. Weijing Medical has raised $71M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in December 2025. The round record for Weijing Medical runs through 2025; nothing later has been disclosed. Investors on record include Guotai Junan Innovation Investment, Hangzhou Yuhang State-owned Capital Investment and Operatio…, ZJVC Venture Capital, Hangzhou Kangji Medical Instruments, Kangji Medical. 5 distinct backers are named across the disclosed rounds.
Weijing Medical at a glance
Total raised
$71M
Latest round
Series B
Latest round date
December 2025
Headquarters
Hangzhou, China
Notable investors
Guotai Junan Innovation Investment, Hangzhou Yuhang State-owned Capital Investment and Operatio…, ZJVC Venture Capital, Hangzhou Kangji Medical Instruments, Kangji Medical
Frequently asked about Weijing Medical funding
How much has Weijing Medical raised?
Weijing Medical has raised $71M in total disclosed funding across the rounds on record.
Who has invested in Weijing Medical?
Guotai Junan Innovation Investment, Hangzhou Yuhang State-owned Capital Investment and Operatio…, ZJVC Venture Capital, Hangzhou Kangji Medical Instruments, Kangji Medical are named among the investors backing Weijing Medical.
What was the latest Weijing Medical funding round?
The most recent disclosed round is a Series B, announced in December 2025.
Where is Weijing Medical based?
Weijing Medical is based in Hangzhou, China.
When did Weijing Medical last raise?
The last disclosed Weijing Medical round closed in December 2025 at Series B.
Every Weijing Medical figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Hangzhou at a similar stage.
